4//SEC Filing
Navon Nadav 4
Accession 0001213900-20-004342
CIK 0001638381other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 9:46 PM ET
Size
5.3 KB
Accession
0001213900-20-004342
Insider Transaction Report
Form 4
Navon Nadav
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-17+90,000→ 90,000 totalExercise: $0.43Exp: 2027-02-17→ Ordinary Shares (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 19, 2021 and thereafter the remaining shares vest and become exercisable in equal quarterly installments through February 19, 2023.
Documents
Issuer
Intec Pharma Ltd.
CIK 0001638381
Entity typeother
Related Parties
1- filerCIK 0001760979
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 9:46 PM ET
- Size
- 5.3 KB